Top 20 Japanese Companies & Their Pipelines 2009PharmaLive Special ReportsOctober 1, 2009 77 Pages - SKU: ENPP2496035 |
|
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Ferring Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Ferring Pharmaceuticals, Inc.’s research and development focus. The report
|
more...
|
$500.00
|
|
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “ADVENTRX Pharmaceuticals - Product Pipeline Review - 2012” provides data on the ADVENTRX Pharmaceuticals’s research and development focus. The report includes information
|
more...
|
$500.00
|
|
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Dainippon Sumitomo Pharma Co., Ltd. - Product Pipeline Review - 2012” provides data on the Dainippon Sumitomo Pharma Co., Ltd.’s
|
more...
|
$500.00
|
|
Eli Lilly and Company – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Eli Lilly and Company – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Eli Lilly and Company - Product Pipeline Review - 2012” provides data on the Eli Lilly and Company’s research and development
|
more...
|
$500.00
|
|
Emergent BioSolutions Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Emergent BioSolutions Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Emergent BioSolutions Inc. - Product Pipeline Review - 2012” provides data on the Emergent BioSolutions Inc.’s research and development focus. The report
|
more...
|
$500.00
|
|
Evotec Aktiengesellschaft – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Evotec Aktiengesellschaft – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Evotec Aktiengesellschaft - Product Pipeline Review - 2012” provides data on the Evotec Aktiengesellschaft’s research and development focus. The report includes information on
|
more...
|
$500.00
|
|
Mitsubishi Tanabe Pharma Corporation – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Mitsubishi Tanabe Pharma Corporation – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Mitsubishi Tanabe Pharma Corporation - Product Pipeline Review - 2012” provides data on the Mitsubishi Tanabe Pharma Corporation’s research and development
|
more...
|
$500.00
|
|
Neuren Pharmaceuticals Limited – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Neuren Pharmaceuticals Limited – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Neuren Pharmaceuticals Limited - Product Pipeline Review - 2012” provides data on the Neuren Pharmaceuticals Limited’s research and development focus. The report
|
more...
|
$500.00
|
|
Newron Pharmaceuticals S.p.A. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Newron Pharmaceuticals S.p.A. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Newron Pharmaceuticals S.p.A. - Product Pipeline Review - 2012” provides data on the Newron Pharmaceuticals S.p.A.’s research and development focus. The report
|
more...
|
$500.00
|
|
Sigma-Tau S.p.A. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Sigma-Tau S.p.A. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Sigma-Tau S.p.A. - Product Pipeline Review - 2012” provides data on the Sigma-Tau S.p.A.’s research and development focus. The report includes information on
|
more...
|
$500.00
|
Related Markets
Prescription Drugs Reports
- Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential
- Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
